Logo image of COP.DE

COMPUGROUP MEDICAL SE & CO K (COP.DE) Stock Fundamental Analysis

FRA:COP - Deutsche Boerse Ag - DE000A288904 - Common Stock - Currency: EUR

22.6  +0.1 (+0.44%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to COP. COP was compared to 12 industry peers in the Health Care Technology industry. While COP is still in line with the averages on profitability rating, there are concerns on its financial health. COP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year COP was profitable.
In the past year COP had a positive cash flow from operations.
In the past 5 years COP has always been profitable.
Each year in the past 5 years COP had a positive operating cash flow.
COP.DE Yearly Net Income VS EBIT VS OCF VS FCFCOP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

1.2 Ratios

COP has a Return On Assets (1.30%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 3.97%, COP is in line with its industry, outperforming 50.00% of the companies in the same industry.
COP has a Return On Invested Capital (3.68%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for COP is below the industry average of 7.83%.
Industry RankSector Rank
ROA 1.3%
ROE 3.97%
ROIC 3.68%
ROA(3y)3.35%
ROA(5y)4.18%
ROE(3y)9.69%
ROE(5y)13.19%
ROIC(3y)4.69%
ROIC(5y)5.95%
COP.DE Yearly ROA, ROE, ROICCOP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 2.18%, COP is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Profit Margin of COP has declined.
COP's Operating Margin of 7.48% is fine compared to the rest of the industry. COP outperforms 66.67% of its industry peers.
In the last couple of years the Operating Margin of COP has declined.
COP has a Gross Margin of 33.03%. This is in the lower half of the industry: COP underperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of COP has declined.
Industry RankSector Rank
OM 7.48%
PM (TTM) 2.18%
GM 33.03%
OM growth 3Y-13.21%
OM growth 5Y-14.58%
PM growth 3Y-23.81%
PM growth 5Y-22.01%
GM growth 3Y-4.53%
GM growth 5Y-3.73%
COP.DE Yearly Profit, Operating, Gross MarginsCOP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COP is destroying value.
COP has about the same amout of shares outstanding than it did 1 year ago.
COP has more shares outstanding than it did 5 years ago.
COP has about the same debt/assets ratio as last year.
COP.DE Yearly Shares OutstandingCOP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
COP.DE Yearly Total Debt VS Total AssetsCOP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 1.82 indicates that COP is not a great score, but indicates only limited risk for bankruptcy at the moment.
COP has a Altman-Z score of 1.82. This is comparable to the rest of the industry: COP outperforms 50.00% of its industry peers.
The Debt to FCF ratio of COP is 11.01, which is on the high side as it means it would take COP, 11.01 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 11.01, COP is in line with its industry, outperforming 58.33% of the companies in the same industry.
A Debt/Equity ratio of 1.22 is on the high side and indicates that COP has dependencies on debt financing.
COP's Debt to Equity ratio of 1.22 is on the low side compared to the rest of the industry. COP is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 11.01
Altman-Z 1.82
ROIC/WACC0.7
WACC5.24%
COP.DE Yearly LT Debt VS Equity VS FCFCOP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

COP has a Current Ratio of 1.03. This is a normal value and indicates that COP is financially healthy and should not expect problems in meeting its short term obligations.
COP has a Current ratio of 1.03. This is in the lower half of the industry: COP underperforms 66.67% of its industry peers.
A Quick Ratio of 0.98 indicates that COP may have some problems paying its short term obligations.
With a Quick ratio value of 0.98, COP is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.98
COP.DE Yearly Current Assets VS Current LiabilitesCOP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

3

3. Growth

3.1 Past

The earnings per share for COP have decreased strongly by -66.96% in the last year.
COP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.83% yearly.
The Revenue has decreased by -4.65% in the past year.
The Revenue has been growing by 10.62% on average over the past years. This is quite good.
EPS 1Y (TTM)-66.96%
EPS 3Y-13.71%
EPS 5Y-14.83%
EPS Q2Q%-46.15%
Revenue 1Y (TTM)-4.65%
Revenue growth 3Y12.36%
Revenue growth 5Y10.62%
Sales Q2Q%-0.8%

3.2 Future

Based on estimates for the next years, COP will show a decrease in Earnings Per Share. The EPS will decrease by -6.67% on average per year.
Based on estimates for the next years, COP will show a small growth in Revenue. The Revenue will grow by 1.57% on average per year.
EPS Next Y-26.11%
EPS Next 2Y-13.45%
EPS Next 3Y-6.67%
EPS Next 5YN/A
Revenue Next Year-2.33%
Revenue Next 2Y0.04%
Revenue Next 3Y1.02%
Revenue Next 5Y1.57%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COP.DE Yearly Revenue VS EstimatesCOP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
COP.DE Yearly EPS VS EstimatesCOP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 47.08 indicates a quite expensive valuation of COP.
COP's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 29.35, COP is valued quite expensively.
Based on the Price/Forward Earnings ratio of 13.68, the valuation of COP can be described as correct.
Based on the Price/Forward Earnings ratio, COP is valued a bit cheaper than 75.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, COP is valued a bit cheaper.
Industry RankSector Rank
PE 47.08
Fwd PE 13.68
COP.DE Price Earnings VS Forward Price EarningsCOP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as COP.
75.00% of the companies in the same industry are more expensive than COP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.7
EV/EBITDA 9.66
COP.DE Per share dataCOP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

COP's earnings are expected to decrease with -6.67% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.45%
EPS Next 3Y-6.67%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.22%, COP is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.21, COP has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, COP's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.22%

5.2 History

The dividend of COP is nicely growing with an annual growth rate of 7.28%!
Dividend Growth(5Y)7.28%
Div Incr Years1
Div Non Decr Years2
COP.DE Yearly Dividends per shareCOP.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

COP pays out 205.57% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of COP has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP205.57%
EPS Next 2Y-13.45%
EPS Next 3Y-6.67%
COP.DE Yearly Income VS Free CF VS DividendCOP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
COP.DE Dividend Payout.COP.DE Dividend Payout, showing the Payout Ratio.COP.DE Dividend Payout.PayoutRetained Earnings

COMPUGROUP MEDICAL SE & CO K

FRA:COP (3/7/2025, 7:00:00 PM)

22.6

+0.1 (+0.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-06 2025-03-06/amc
Earnings (Next)04-30 2025-04-30
Inst Owners18.37%
Inst Owner ChangeN/A
Ins Owners53.51%
Ins Owner ChangeN/A
Market Cap1.21B
Analysts70
Price Target21.32 (-5.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.22%
Yearly Dividend0.5
Dividend Growth(5Y)7.28%
DP205.57%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-17.6%
PT rev (3m)-15.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE 47.08
Fwd PE 13.68
P/S 1.05
P/FCF 15.7
P/OCF 8.23
P/B 1.91
P/tB N/A
EV/EBITDA 9.66
EPS(TTM)0.48
EY2.12%
EPS(NY)1.65
Fwd EY7.31%
FCF(TTM)1.44
FCFY6.37%
OCF(TTM)2.75
OCFY12.15%
SpS21.44
BVpS11.8
TBVpS-13.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.3%
ROE 3.97%
ROCE 5.49%
ROIC 3.68%
ROICexc 3.88%
ROICexgc 39.78%
OM 7.48%
PM (TTM) 2.18%
GM 33.03%
FCFM 6.71%
ROA(3y)3.35%
ROA(5y)4.18%
ROE(3y)9.69%
ROE(5y)13.19%
ROIC(3y)4.69%
ROIC(5y)5.95%
ROICexc(3y)5%
ROICexc(5y)6.32%
ROICexgc(3y)57.88%
ROICexgc(5y)61.98%
ROCE(3y)7.01%
ROCE(5y)8.91%
ROICexcg growth 3Y-15.48%
ROICexcg growth 5Y-14.57%
ROICexc growth 3Y-9.12%
ROICexc growth 5Y-20.09%
OM growth 3Y-13.21%
OM growth 5Y-14.58%
PM growth 3Y-23.81%
PM growth 5Y-22.01%
GM growth 3Y-4.53%
GM growth 5Y-3.73%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 11.01
Debt/EBITDA 3.79
Cap/Depr 59.04%
Cap/Sales 6.09%
Interest Coverage 250
Cash Conversion 71.95%
Profit Quality 307.33%
Current Ratio 1.03
Quick Ratio 0.98
Altman-Z 1.82
F-Score4
WACC5.24%
ROIC/WACC0.7
Cap/Depr(3y)63.72%
Cap/Depr(5y)66.87%
Cap/Sales(3y)6.48%
Cap/Sales(5y)6.39%
Profit Quality(3y)157.58%
Profit Quality(5y)140.57%
High Growth Momentum
Growth
EPS 1Y (TTM)-66.96%
EPS 3Y-13.71%
EPS 5Y-14.83%
EPS Q2Q%-46.15%
EPS Next Y-26.11%
EPS Next 2Y-13.45%
EPS Next 3Y-6.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.65%
Revenue growth 3Y12.36%
Revenue growth 5Y10.62%
Sales Q2Q%-0.8%
Revenue Next Year-2.33%
Revenue Next 2Y0.04%
Revenue Next 3Y1.02%
Revenue Next 5Y1.57%
EBIT growth 1Y-43.05%
EBIT growth 3Y-2.48%
EBIT growth 5Y-5.51%
EBIT Next Year34.68%
EBIT Next 3Y15.14%
EBIT Next 5Y9.93%
FCF growth 1Y72.47%
FCF growth 3Y5.84%
FCF growth 5Y3.07%
OCF growth 1Y20.85%
OCF growth 3Y6.19%
OCF growth 5Y5.66%